Aridis Pharmaceuticals (ARDS) Stock Forecast for 2024–2028. Sell or Buy Prediction
All stock predictions
All currency forecasts
All cryptocurrency predictions

This Month Predictions for ARDS stock
Aridis Pharmaceuticals, Inc. Analysis
ARDS Stock News


Popular stocks:
Suncor Energy
Amazon
Square
Etsy
Tilray
Energy Transfer

TOP Stocks:
Microsoft
Apple
Tesla
Alibaba
Amazon
American Airlines
NVIDIA
Adobe

Shares of other companies:
Cerence
Vertiv Holdings
Embark Technology
MarketAxess Holdings
Autodesk
Clever Leaves Holdings
Electronic Arts
Fox
Toast
Ebang International Holdings


Financial News

Popular Stocks Analysis

Helpful Highlights
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
  1. Home
    2. »
  2. Stock forecasts
    3. »
  3. ARDS

Aridis Pharmaceuticals (ARDS) Stock Forecast for 2024–2028. Sell or Buy?

Updated: April 17, 2024 (17:07)

Sector: Healthcare

The share price of Aridis Pharmaceuticals, Inc. (ARDS) now

Latest session on the 17th of April for
Aridis Pharmaceuticals, Inc. is negative
Trading Volume: 27515
Open: 0.07 /  High: 0.072 /  Low: 0.065
What analysts predict: $
52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Aridis Pharmaceuticals stocks, the 50-day moving average is the support level today.

For Aridis Pharmaceuticals stocks, the 200-day moving average is the support level today.

Are you interested in Aridis Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aridis Pharmaceuticals stock price in 2024, 2025, 2026, 2027, 2028. How much will one Aridis Pharmaceuticals share be worth in 2024 - 2028?

When should I take profit in Aridis Pharmaceuticals stock? When should I record a loss on Aridis Pharmaceuticals stock? What are analysts' forecasts for Aridis Pharmaceuticals stock? What is the future of Aridis Pharmaceuticals stock? We forecast Aridis Pharmaceuticals stock performance using neural networks based on historical data on Aridis Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Aridis Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Aridis Pharmaceuticals shares. This happens once a day.


Historical and forecast chart of Aridis Pharmaceuticals stock

The chart below shows the historical price of Aridis Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Aridis Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Aridis Pharmaceuticals, Inc. Is a biopharmaceutical company specializing in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAbs) to treat infections. MABs represent a treatment approach that allows the human immune system to fight infections and is designed to overcome the disadvantages associated with current therapies, such as increased drug resistance, short response times, negative effects on the human microbiome, and lack of differentiation between treatment alternatives. Its product pipeline includes human MABs that target specific pathogens associated with bacterial infections, most notably hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP). Its leading candidate product, AR-301, targets the alpha toxin produced by the gram-positive bacteria Staphylococcus aureus, a common pathogen associated with HAP and VAP. Its AR-101 (Aerumab) is a fully human immunoglobulin M targeting P. aeruginosa serotype O11.

Aridis Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
Apr 19 0.07 0.07 0.08 4.73
Apr 20 0.07 0.07 0.07 4.34
Apr 21 0.07 0.07 0.07 3.61
Apr 22 0.07 0.07 0.07 4.26
Apr 23 0.07 0.07 0.07 4.54
Apr 24 0.07 0.07 0.07 6.40
Apr 25 0.07 0.07 0.07 3.98
Apr 26 0.07 0.07 0.07 5.70
Apr 27 0.07 0.07 0.07 3.91
Apr 28 0.07 0.07 0.07 2.91
Apr 29 0.07 0.07 0.07 2.10
Apr 30 0.07 0.07 0.07 4.69
May 01 0.07 0.07 0.07 4.40
May 02 0.07 0.07 0.07 5.11
May 03 0.07 0.07 0.07 3.31
May 04 0.08 0.07 0.08 3.81
May 05 0.08 0.07 0.08 4.30
May 06 0.07 0.07 0.08 3.36
May 07 0.07 0.07 0.07 2.97
May 08 0.07 0.07 0.08 3.86
May 09 0.07 0.07 0.08 4.91
May 10 0.07 0.07 0.08 3.54
May 11 0.07 0.07 0.08 4.34
May 12 0.08 0.07 0.08 4.31
May 13 0.08 0.08 0.08 2.27
May 14 0.08 0.08 0.08 5.80
May 15 0.08 0.08 0.08 3.74
May 16 0.08 0.07 0.08 2.23
May 17 0.08 0.08 0.08 4.13
May 18 0.07 0.07 0.08 3.84

Aridis Pharmaceuticals Daily Price Targets


Aridis Pharmaceuticals Stock Forecast 04-19-2024.

Forecast target price for 04-19-2024: $0.07.
Positive dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 4.515%.
Pessimistic target level: 0.07
Optimistic target level: 0.08

Aridis Pharmaceuticals Stock Forecast 04-20-2024.

Forecast target price for 04-20-2024: $0.07.
Negative dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 4.158%.
Pessimistic target level: 0.07
Optimistic target level: 0.07

Aridis Pharmaceuticals Stock Forecast 04-21-2024.

Forecast target price for 04-21-2024: $0.07.
Positive dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 3.481%.
Pessimistic target level: 0.07
Optimistic target level: 0.07

Aridis Pharmaceuticals Stock Forecast 04-22-2024.

Forecast target price for 04-22-2024: $0.07.
Negative dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 4.088%.
Pessimistic target level: 0.07
Optimistic target level: 0.07

Aridis Pharmaceuticals Stock Forecast 04-23-2024.

Forecast target price for 04-23-2024: $0.07.
Negative dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 4.343%.
Pessimistic target level: 0.07
Optimistic target level: 0.07

Aridis Pharmaceuticals Stock Forecast 04-24-2024.

Forecast target price for 04-24-2024: $0.07.
Positive dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 6.017%.
Pessimistic target level: 0.07
Optimistic target level: 0.07

ARDS (ARDS) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
May. 0.08 0.08 0.09 15.08
Jun. 0.08 0.07 0.09 16.72
Jul. 0.08 0.07 0.09 14.76
Aug. 0.09 0.08 0.09 16.84
Sep. 0.09 0.08 0.10 17.12
Oct. 0.10 0.09 0.11 13.52
Nov. 0.11 0.09 0.12 21.70
Dec. 0.10 0.10 0.11 9.39
Full forecast for 2024

Aridis Pharmaceuticals forecast for this year


Aridis Pharmaceuticals Stock Prediction for May 2024

An uptrend is forecast for this month with an optimal target price of $0.0796368. Pessimistic: $0.08. Optimistic: $0.09


Aridis Pharmaceuticals Stock Prediction for Jun 2024

An uptrend is forecast for this month with an optimal target price of $0.0816755. Pessimistic: $0.07. Optimistic: $0.09


Aridis Pharmaceuticals Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $0.0811528. Pessimistic: $0.07. Optimistic: $0.09


Aridis Pharmaceuticals Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $0.0867361. Pessimistic: $0.08. Optimistic: $0.09


Aridis Pharmaceuticals Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $0.0893729. Pessimistic: $0.08. Optimistic: $0.10


Aridis Pharmaceuticals Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $0.103244. Pessimistic: $0.09. Optimistic: $0.11


Aridis Pharmaceuticals Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $0.106878. Pessimistic: $0.09. Optimistic: $0.12


Aridis Pharmaceuticals Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $0.103116. Pessimistic: $0.10. Optimistic: $0.11



Aridis Pharmaceuticals (ARDS) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 0.10 0.09 0.11 17.14
Feb 0.09 0.09 0.10 13.59
Mar 0.09 0.08 0.09 10.55
Apr 0.09 0.08 0.10 18.43
May 0.09 0.08 0.10 13.23
Jun 0.10 0.10 0.11 14.33
Jul 0.12 0.11 0.13 20.03
Aug 0.13 0.12 0.14 14.39
Sep 0.14 0.13 0.16 15.40
Oct 0.15 0.13 0.15 15.81
Nov 0.15 0.15 0.17 13.45
Dec 0.14 0.14 0.15 7.50
Full forecast for 2025

Aridis Pharmaceuticals (ARDS) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 0.15 0.14 0.17 14.08
Feb 0.15 0.14 0.16 13.09
Mar 0.15 0.14 0.16 11.33
Apr 0.14 0.13 0.16 20.12
May 0.17 0.15 0.18 12.99
Jun 0.17 0.15 0.19 21.63
Jul 0.18 0.17 0.20 13.36
Aug 0.16 0.15 0.18 19.74
Sep 0.16 0.15 0.18 12.74
Oct 0.14 0.14 0.16 13.51
Nov 0.15 0.13 0.16 19.01
Dec 0.15 0.13 0.16 18.44
Full forecast for 2026

Aridis Pharmaceuticals (ARDS) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 0.14 0.13 0.15 9.65
Feb 0.13 0.12 0.14 14.22
Mar 0.14 0.12 0.15 15.67
Apr 0.13 0.12 0.14 12.57
May 0.15 0.14 0.16 13.98
Jun 0.15 0.14 0.15 10.35
Jul 0.14 0.12 0.15 18.64
Aug 0.13 0.13 0.14 8.81
Sep 0.14 0.13 0.15 15.86
Oct 0.14 0.13 0.15 13.32
Nov 0.15 0.14 0.16 11.47
Dec 0.15 0.14 0.17 13.89
Full forecast for 2027

Aridis Pharmaceuticals (ARDS) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 0.15 0.13 0.16 19.60
Feb 0.16 0.15 0.18 15.46
Mar 0.18 0.16 0.19 13.03
Apr 0.19 0.18 0.21 14.54
May 0.21 0.20 0.24 15.38
Jun 0.24 0.22 0.26 15.16
Jul 0.25 0.24 0.28 12.17
Aug 0.27 0.25 0.30 16.31
Sep 0.29 0.26 0.31 15.63
Oct 0.30 0.26 0.33 20.23
Nov 0.30 0.27 0.33 17.20
Dec 0.30 0.28 0.33 14.05
Full forecast for 2028

Aridis Pharmaceuticals information and performance

Aridis Pharmaceuticals Address

N/A

Market Capitalization: N/A $

Market capitalization of the Aridis Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ARDS shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Aridis Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector

Cue Health Inc. (HLTH)
bluebird bio, Inc. (BLUE)
GoodRx Holdings, Inc. (GDRX)
ImmunoGen, Inc. (IMGN)
PerkinElmer, Inc. (PKI)
Mind Medicine (MindMed) Inc. (MNMD)
Oramed Pharmaceuticals Inc. (ORMP)
Codex DNA, Inc. (DNAY)
Fulcrum Therapeutics, Inc. (FULC)
Sundial Growers Inc. (SNDL)


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.


This website uses cookies to ensure you get the best experience on our website